Publisher: Maaal International Media Company
License: 465734
Middle East Pharmaceutical Industries (Avalon Pharma) said on Sunday that shareholders approved the transfer of SAR 25.2 million in statutory reserves to retained earnings during its Extraordinary General Assembly Meeting.
The reclassification relates to the balance reported in Avalon’s audited financial statements for the year ended Dec. 31, 2024, the company said in a statement.